Dementia in SPG4 hereditary spastic paraplegia: Clinical, genetic, and neuropathologic evidence

S. Murphy, G. Gorman, C. Beetz, P. Byrne, M. Dytko, P. McMonagle, K. Kinsella, M. Farrell, M. Hutchinson

Research output: Contribution to journalArticlepeer-review

45 Scopus citations

Abstract

BACKGROUND: Cognitive impairment and dementia has been reported in autosomal dominant hereditary spastic paraparesis (HSP) linked to the SPG4 locus. There has only been one postmortem examination described; not all accept that progressive cognitive decline is a feature of this disorder. OBJECTIVE: A family with SPG4-HSP known to have a deletion of exon 17 in the spastin gene (SPG4delEx17) was cognitively assessed over a 7-year period. The index family member died and a postmortem examination was performed. METHODS: Thirteen family members older than 40 years were clinically and cognitively assessed using the Cambridge Cognitive Assessment over a 7-year period. The presence of SPG4delEx17 was assessed; a neuropathologic examination of the brain of the index family member was performed. RESULTS: Cognitive decline occurred in 6 of the 13 family members and in all 4 older than 60 years. Two genetic deletions were identified: SPG4delEx17 in 12 of the 13 family members and a deletion of SPG6 (SPG6del) in 5. Eight individuals had the SPG4delEx17 deletion only; 4 had evidence of progressive cognitive impairment. Four family members had both SPG4delEx17 and SPG6del; 2 of these had cognitive impairment. One family member with the SPG6del alone had neither HSP nor cognitive impairment. The index case with both deletions died with dementia; the brain showed widespread ubiquitin positivity within the neocortex and white matter. CONCLUSION: Cognitive decline and dementia is a feature of SPG4-HSP due to a deletion of exon 17 of the spastin gene.

Original languageEnglish
Pages (from-to)378-384
Number of pages7
JournalNeurology
Volume73
Issue number5
DOIs
StatePublished - Aug 2009
Externally publishedYes

Fingerprint

Dive into the research topics of 'Dementia in SPG4 hereditary spastic paraplegia: Clinical, genetic, and neuropathologic evidence'. Together they form a unique fingerprint.

Cite this